{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T04:04:33Z","timestamp":1791777873878,"version":"4.3.4"},"reference-count":104,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Research"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.neures.2011.05.008","type":"journal-article","created":{"date-parts":[[2011,5,23]],"date-time":"2011-05-23T00:32:32Z","timestamp":1306110752000},"page":"339-348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":168,"title":["Protein aggregate spreading in neurodegenerative diseases: Problems and perspectives"],"prefix":"10.1016","volume":"70","author":[{"given":"Seung-Jae","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Sun","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliezer","family":"Masliah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He-Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neures.2011.05.008_bib0005","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev.neuro.31.060407.125620","article-title":"The prion's elusive reason for being","volume":"31","author":"Aguzzi","year":"2008","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neures.2011.05.008_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2011.01.029","article-title":"Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission","author":"Alvarez-Erviti","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neures.2011.05.008_bib0015","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nature02998","article-title":"Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death","volume":"431","author":"Arrasate","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.neures.2011.05.008_bib0020","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1046\/j.1471-4159.2002.01192.x","article-title":"The neuropathogenic contributions of lysosomal dysfunction","volume":"83","author":"Bahr","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neures.2011.05.008_bib0025","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1126\/science.1141448","article-title":"Adapting proteostasis for disease intervention","volume":"319","author":"Balch","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.neures.2011.05.008_bib0030","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1126\/science.292.5521.1552","article-title":"Impairment of the ubiquitin-proteasome system by protein aggregation","volume":"292","author":"Bence","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.neures.2011.05.008_bib0035","doi-asserted-by":"crossref","first-page":"14711","DOI":"10.1016\/S0021-9258(17)36683-8","article-title":"Rapid anterograde axonal transport of the cellular prion glycoprotein in the peripheral and central nervous systems","volume":"269","author":"Borchelt","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neures.2011.05.008_bib0040","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","article-title":"Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry","volume":"112","author":"Braak","year":"2006","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neures.2011.05.008_bib0045","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neures.2011.05.008_bib0050","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.neurobiolaging.2003.12.015","article-title":"Alzheimer's disease: intraneuronal alterations precede insoluble amyloid-beta formation","volume":"25","author":"Braak","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neures.2011.05.008_bib0055","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neures.2011.05.008_bib0060","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev.neuro.31.060407.125529","article-title":"Active and passive immunotherapy for neurodegenerative disorders","volume":"31","author":"Brody","year":"2008","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neures.2011.05.008_bib0065","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/ana.21541","article-title":"A critical evaluation of the Braak staging scheme for Parkinson's disease","volume":"64","author":"Burke","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neures.2011.05.008_bib0070","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0197-4580(97)00035-3","article-title":"Spatial, temporal and numeric analysis of Alzheimer changes in the nucleus coeruleus","volume":"18","author":"Busch","year":"1997","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neures.2011.05.008_bib0075","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1146\/annurev.biochem.78.082907.145410","article-title":"Getting a grip on prions: oligomers, amyloids, and pathological membrane interactions","volume":"78","author":"Caughey","year":"2009","journal-title":"Annu. Rev. Biochem"},{"key":"10.1016\/j.neures.2011.05.008_bib0080","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuron.2008.02.003","article-title":"Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo","volume":"58","author":"Cirrito","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.neures.2011.05.008_bib0085","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.neuron.2005.10.028","article-title":"Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo","volume":"48","author":"Cirrito","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.neures.2011.05.008_bib0090","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/ncb1901","article-title":"Transmission and spreading of tauopathy in transgenic mouse brain","volume":"11","author":"Clavaguera","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.neures.2011.05.008_bib0095","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.biocel.2007.07.013","article-title":"Mechanisms of A beta mediated neurodegeneration in Alzheimer's disease","volume":"40","author":"Crouch","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.neures.2011.05.008_bib0100","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1471-4159.2009.06324.x","article-title":"Seeding induced by alpha-synuclein oligomers provides evidence for spreading of alpha-synuclein pathology","volume":"111","author":"Danzer","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neures.2011.05.008_bib0105","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1096\/fj.10-164624","article-title":"Heat-shock protein 70 modulates toxic extracellular alpha-synuclein oligomers and rescues trans-synaptic toxicity","volume":"25","author":"Danzer","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.neures.2011.05.008_bib0110","doi-asserted-by":"crossref","first-page":"13010","DOI":"10.1073\/pnas.0903691106","article-title":"Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein","volume":"106","author":"Desplats","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neures.2011.05.008_bib0115","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neures.2011.05.008_bib0120","doi-asserted-by":"crossref","first-page":"12926","DOI":"10.1073\/pnas.0903200106","article-title":"Induction of cerebral beta-amyloidosis: intracerebral versus systemic Abeta inoculation","volume":"106","author":"Eisele","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neures.2011.05.008_bib0125","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1126\/science.1194516","article-title":"Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis","volume":"330","author":"Eisele","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.neures.2011.05.008_bib0130","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1096\/fj.03-0098fje","article-title":"Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma","volume":"17","author":"El-Agnaf","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.neures.2011.05.008_bib0135","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1096\/fj.03-1449com","article-title":"Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease","volume":"20","author":"El-Agnaf","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.neures.2011.05.008_bib0140","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.1523\/JNEUROSCI.5699-09.2010","article-title":"Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival","volume":"30","author":"Emmanouilidou","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neures.2011.05.008_bib0145","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/cne.22034","article-title":"Development of vaccination approaches for the treatment of neurological diseases","volume":"515","author":"Federoff","year":"2009","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neures.2011.05.008_bib0150","doi-asserted-by":"crossref","first-page":"9683","DOI":"10.1073\/pnas.0308413101","article-title":"Cells release prions in association with exosomes","volume":"101","author":"Fevrier","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neures.2011.05.008_bib0155","doi-asserted-by":"crossref","first-page":"10913","DOI":"10.1523\/JNEUROSCI.2922-05.2005","article-title":"Neural activity controls the synaptic accumulation of {alpha}-synuclein","volume":"25","author":"Fortin","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neures.2011.05.008_bib0160","doi-asserted-by":"crossref","first-page":"12845","DOI":"10.1074\/jbc.M808759200","article-title":"Propagation of tau misfolding from the outside to the inside of a cell","volume":"284","author":"Frost","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neures.2011.05.008_bib0165","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1074\/jbc.M805627200","article-title":"Conformational diversity of wild-type Tau fibrils specified by templated conformation change","volume":"284","author":"Frost","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neures.2011.05.008_bib0170","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nrm1423","article-title":"The cell biology of lysosomal storage disorders","volume":"5","author":"Futerman","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.neures.2011.05.008_bib0175","doi-asserted-by":"crossref","first-page":"7687","DOI":"10.1523\/JNEUROSCI.0143-07.2008","article-title":"Neuroinflammation and oxidation\/nitration of alpha-synuclein linked to dopaminergic neurodegeneration","volume":"28","author":"Gao","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neures.2011.05.008_bib0180","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1126\/science.1124514","article-title":"Progressive disruption of cellular protein folding in models of polyglutamine diseases","volume":"311","author":"Gidalevitz","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.neures.2011.05.008_bib0185","doi-asserted-by":"crossref","first-page":"29639","DOI":"10.1074\/jbc.R800016200","article-title":"Structural classification of toxic amyloid oligomers","volume":"283","author":"Glabe","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neures.2011.05.008_bib0190","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/35081564","article-title":"Alpha-synuclein and neurodegenerative diseases","volume":"2","author":"Goedert","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neures.2011.05.008_bib0195","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1212\/WNL.53.6.1284","article-title":"Clinical and quantitative pathologic correlates of dementia with Lewy bodies","volume":"53","author":"Gomez-Tortosa","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.neures.2011.05.008_bib0200","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ncb1841","article-title":"Prions hijack tunnelling nanotubes for intercellular spread","volume":"11","author":"Gousset","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.neures.2011.05.008_bib0205","doi-asserted-by":"crossref","first-page":"15317","DOI":"10.1074\/jbc.M110.209296","article-title":"Seeding of normal tau by pathological tau conformers drives pathogenesis of Alzheimer-like tangles","volume":"286","author":"Guo","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neures.2011.05.008_bib0210","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1523\/JNEUROSCI.19-07-02522.1999","article-title":"Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology","volume":"19","author":"Gutekunst","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neures.2011.05.008_bib0215","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/mds.23455","article-title":"Glia: initiators and progressors of pathology in Parkinson's disease","volume":"26","author":"Halliday","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neures.2011.05.008_bib0220","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1172\/JCI43366","article-title":"alpha-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells","volume":"121","author":"Hansen","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neures.2011.05.008_bib0225","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.neuron.2006.09.016","article-title":"A hundred years of Alzheimer's disease research","volume":"52","author":"Hardy","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.neures.2011.05.008_bib0230","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0140-6736(08)61075-2","article-title":"Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial","volume":"372","author":"Holmes","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.neures.2011.05.008_bib0235","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.0911281106","article-title":"Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide","author":"Hu","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neures.2011.05.008_bib0240","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1471-4159.2010.06695.x","article-title":"Non-classical exocytosis of alpha-synuclein is sensitive to folding states and promoted under stress conditions","volume":"113","author":"Jang","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neures.2011.05.008_bib0245","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/0092-8674(93)90635-4","article-title":"Seeding \u201cone-dimensional crystallization\u201d of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?","volume":"73","author":"Jarrett","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.neures.2011.05.008_bib0250","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.bbamem.2007.01.022","article-title":"Membrane interaction of islet amyloid polypeptide","volume":"1768","author":"Jayasinghe","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neures.2011.05.008_bib0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-008-0406-y","article-title":"A critical reappraisal of current staging of Lewy-related pathology in human brain","volume":"116","author":"Jellinger","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neures.2011.05.008_bib0260","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0896-6273(03)00124-7","article-title":"APP processing and synaptic function","volume":"37","author":"Kamenetz","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.neures.2011.05.008_bib0265","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1523\/JNEUROSCI.20-10-03606.2000","article-title":"Evidence for seeding of beta-amyloid by intracerebral infusion of Alzheimer brain extracts in beta-amyloid precursor protein-transgenic mice","volume":"20","author":"Kane","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neures.2011.05.008_bib0270","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","article-title":"Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis","volume":"300","author":"Kayed","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neures.2011.05.008_bib0275","doi-asserted-by":"crossref","first-page":"9838","DOI":"10.1523\/JNEUROSCI.2557-04.2004","article-title":"Microglial phagocytosis of fibrillar beta-amyloid through a beta1 integrin-dependent mechanism","volume":"24","author":"Koenigsknecht","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neures.2011.05.008_bib0280","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nm1058","article-title":"Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides","volume":"10","author":"Koistinaho","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.neures.2011.05.008_bib0285","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nm1747","article-title":"Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease","volume":"14","author":"Kordower","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.neures.2011.05.008_bib0290","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1002\/mds.22369","article-title":"Transplanted dopaminergic neurons develop PD pathologic changes: a second case report","volume":"23","author":"Kordower","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neures.2011.05.008_bib0295","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.1523\/JNEUROSCI.0692-05.2005","article-title":"Intravesicular localization and exocytosis of alpha-synuclein and its aggregates","volume":"25","author":"Lee","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neures.2011.05.008_bib0300","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.biocel.2008.01.017","article-title":"Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein","volume":"40","author":"Lee","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.neures.2011.05.008_bib0305","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.bbrc.2008.05.045","article-title":"Clearance and deposition of extracellular alpha-synuclein aggregates in microglia","volume":"372","author":"Lee","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neures.2011.05.008_bib0310","doi-asserted-by":"crossref","first-page":"9262","DOI":"10.1074\/jbc.M109.081125","article-title":"Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies","volume":"285","author":"Lee","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neures.2011.05.008_bib0315","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.4161\/cc.9.14.12590","article-title":"Multiple non-cell autonomous actions of alpha-synuclein in neurodegenerative diseases: is there a direct link?","volume":"9","author":"Lee","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.neures.2011.05.008_bib0320","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.1100195","article-title":"Synthetic mammalian prions","volume":"305","author":"Legname","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.neures.2011.05.008_bib0325","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nm1746","article-title":"Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation","volume":"14","author":"Li","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.neures.2011.05.008_bib0330","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1046\/j.1471-4159.2003.02166.x","article-title":"Axonal transport of human alpha-synuclein slows with aging but is not affected by familial Parkinson's disease-linked mutations","volume":"88","author":"Li","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neures.2011.05.008_bib0335","doi-asserted-by":"crossref","first-page":"20051","DOI":"10.1073\/pnas.0908005106","article-title":"Exogenous {alpha}-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells","volume":"106","author":"Luk","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neures.2011.05.008_bib0340","doi-asserted-by":"crossref","first-page":"5207","DOI":"10.1523\/JNEUROSCI.0653-05.2005","article-title":"Uptake and neuritic transport of scrapie prion protein coincident with infection of neuronal cells","volume":"25","author":"Magalhaes","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neures.2011.05.008_bib0345","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1523\/JNEUROSCI.5572-08.2009","article-title":"Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosis","volume":"29","author":"Mandrekar","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neures.2011.05.008_bib0350","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.neuron.2005.05.010","article-title":"Effects of alpha-synuclein immunization in a mouse model of Parkinson's disease","volume":"46","author":"Masliah","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.neures.2011.05.008_bib0355","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1197623","article-title":"Decreased clearance of CNS beta-amyloid in Alzheimer's disease","volume":"330","author":"Mawuenyega","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.neures.2011.05.008_bib0360","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nm1752","article-title":"Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years","volume":"14","author":"Mendez","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.neures.2011.05.008_bib0365","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1126\/science.1131864","article-title":"Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host","volume":"313","author":"Meyer-Luehmann","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.neures.2011.05.008_bib0370","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1046\/j.1471-4159.2003.02150.x","article-title":"Enhanced detection and retrograde axonal transport of PrPc in peripheral nerve","volume":"88","author":"Moya","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neures.2011.05.008_bib0375","doi-asserted-by":"crossref","first-page":"34885","DOI":"10.1074\/jbc.M110.148460","article-title":"Seeded aggregation and toxicity of {alpha}-synuclein and tau: cellular models of neurodegenerative diseases","volume":"285","author":"Nonaka","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neures.2011.05.008_bib0380","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1007\/s00018-008-7589-1","article-title":"Mitochondrial association of alpha-synuclein causes oxidative stress","volume":"65","author":"Parihar","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.neures.2011.05.008_bib0385","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1126\/science.1105850","article-title":"Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils","volume":"307","author":"Petkova","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.neures.2011.05.008_bib0390","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJM200105173442006","article-title":"Shattuck lecture \u2013 neurodegenerative diseases and prions","volume":"344","author":"Prusiner","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neures.2011.05.008_bib0395","doi-asserted-by":"crossref","first-page":"11172","DOI":"10.1073\/pnas.0603838103","article-title":"Alzheimer's disease beta-amyloid peptides are released in association with exosomes","volume":"103","author":"Rajendran","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neures.2011.05.008_bib0400","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/ncb1830","article-title":"Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates","volume":"11","author":"Ren","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.neures.2011.05.008_bib0405","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.1523\/JNEUROSCI.1146-08.2008","article-title":"Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid beta 1-42 and delay the cognitive decline in a mouse model of Alzheimer's disease","volume":"28","author":"Richard","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neures.2011.05.008_bib0410","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1474-4422(10)70043-0","article-title":"11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study","volume":"9","author":"Rinne","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neures.2011.05.008_bib0415","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/brain\/awn025","article-title":"Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity","volume":"131","author":"Rosas","year":"2008","journal-title":"Brain"},{"issue":"Suppl.","key":"10.1016\/j.neures.2011.05.008_bib0420","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/nm1066","article-title":"Protein aggregation and neurodegenerative disease","volume":"10","author":"Ross","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.neures.2011.05.008_bib0425","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1523\/JNEUROSCI.4999-06.2007","article-title":"Rapid and intermittent cotransport of slow component-b proteins","volume":"27","author":"Roy","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neures.2011.05.008_bib0430","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/jnen\/62.6.644","article-title":"Accumulation of phosphorylated alpha-synuclein in aging human brain","volume":"62","author":"Saito","year":"2003","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neures.2011.05.008_bib0435","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nature09768","article-title":"Prion propagation and toxicity in vivo occur in two distinct mechanistic phases","volume":"470","author":"Sandberg","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.neures.2011.05.008_bib0440","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s004019900178","article-title":"Evolution of Alzheimer's disease-related cytoskeletal changes in the basal nucleus of Meynert","volume":"100","author":"Sassin","year":"2000","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neures.2011.05.008_bib0445","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/nature02264","article-title":"Folding proteins in fatal ways","volume":"426","author":"Selkoe","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.neures.2011.05.008_bib0450","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/ncb1104-1054","article-title":"Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases","volume":"6","author":"Selkoe","year":"2004","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.neures.2011.05.008_bib0455","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3233\/JAD-2008-15202","article-title":"Immunotherapy targeting pathological tau protein in Alzheimer's disease and related tauopathies","volume":"15","author":"Sigurdsson","year":"2008","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.neures.2011.05.008_bib0460","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nature03989","article-title":"The most infectious prion protein particles","volume":"437","author":"Silveira","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.neures.2011.05.008_bib0465","doi-asserted-by":"crossref","first-page":"10998","DOI":"10.1073\/pnas.0700848104","article-title":"Amyloidogenic potential of foie gras","volume":"104","author":"Solomon","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neures.2011.05.008_bib0470","doi-asserted-by":"crossref","first-page":"e3308","DOI":"10.1371\/journal.pone.0003308","article-title":"AA-amyloidosis can be transferred by peripheral blood monocytes","volume":"3","author":"Sponarova","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.neures.2011.05.008_bib0475","doi-asserted-by":"crossref","first-page":"25216","DOI":"10.1074\/jbc.M503341200","article-title":"Proteolytic cleavage of extracellular secreted {alpha}-synuclein via matrix metalloproteinases","volume":"280","author":"Sung","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neures.2011.05.008_bib0480","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1093\/brain\/awl249","article-title":"Role of toll-like receptor signalling in Abeta uptake and clearance","volume":"129","author":"Tahara","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.neures.2011.05.008_bib0485","doi-asserted-by":"crossref","first-page":"9704","DOI":"10.1523\/JNEUROSCI.2292-09.2009","article-title":"Synaptic activity reduces intraneuronal Abeta, promotes APP transport to synapses, and protects against Abeta-related synaptic alterations","volume":"29","author":"Tampellini","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neures.2011.05.008_bib0490","first-page":"605","article-title":"Clearance of Alzheimer's Abeta peptide: the many roads to perdition","volume":"43","author":"Tanzi","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.neures.2011.05.008_bib0495","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.neuroscience.2006.04.061","article-title":"Activity-related redistribution of presynaptic proteins at the active zone","volume":"141","author":"Tao-Cheng","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.neures.2011.05.008_bib0500","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nrm2993","article-title":"Cellular strategies for controlling protein aggregation","volume":"11","author":"Tyedmers","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.neures.2011.05.008_bib0505","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/j.1471-4159.1993.tb09823.x","article-title":"Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay","volume":"61","author":"Vandermeeren","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neures.2011.05.008_bib0510","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1471-4159.2010.06592.x","article-title":"A novel, high-efficiency cellular model of fibrillar alpha-synuclein inclusions and the examination of mutations that inhibit amyloid formation","volume":"113","author":"Waxman","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neures.2011.05.008_bib0515","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nm838","article-title":"Adult mouse astrocytes degrade amyloid-beta in vitro and in situ","volume":"9","author":"Wyss-Coray","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.neures.2011.05.008_bib0520","doi-asserted-by":"crossref","first-page":"7940","DOI":"10.1074\/jbc.M807482200","article-title":"Conversion of wild-type alpha-synuclein into mutant-type fibrils and its propagation in the presence of A30P mutant","volume":"284","author":"Yonetani","year":"2009","journal-title":"J. Biol. Chem."}],"container-title":["Neuroscience Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168010211001325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168010211001325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T10:21:56Z","timestamp":1759141316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168010211001325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":104,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0168010211001325"],"URL":"https:\/\/doi.org\/10.1016\/j.neures.2011.05.008","relation":{},"ISSN":["0168-0102"],"issn-type":[{"value":"0168-0102","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protein aggregate spreading in neurodegenerative diseases: Problems and perspectives","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neures.2011.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ireland Ltd and the Japan Neuroscience Society. All rights reserved.","name":"copyright","label":"Copyright"}]}}